APA (7th ed.) Citation

NW, P., BM, B., VL, K., MC, A., LM, G., BV, D. S., . . . VLG, C. (2024). Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice. Frontiers in immunology, 15, 1347318. https://doi.org/10.3389/fimmu.2024.1347318

Chicago Style (17th ed.) Citation

NW, Preite, et al. "Blocking the CTLA-4 and PD-1 Pathways During Pulmonary Paracoccidioidomycosis Improves Immunity, Reduces Disease Severity, and Increases the Survival of Infected Mice." Frontiers in Immunology 15 (2024): 1347318. https://doi.org/10.3389/fimmu.2024.1347318.

MLA (9th ed.) Citation

NW, Preite, et al. "Blocking the CTLA-4 and PD-1 Pathways During Pulmonary Paracoccidioidomycosis Improves Immunity, Reduces Disease Severity, and Increases the Survival of Infected Mice." Frontiers in Immunology, vol. 15, 2024, p. 1347318, https://doi.org/10.3389/fimmu.2024.1347318.